je.st
news
AstraZeneca cancer drug, companion test approved
2014-12-19 21:03:21| Biotech - Topix.net
U.S. regulators on Friday granted accelerated approval to the first in a new class of targeted drugs for ovarian cancer, Lynparza from British drugmaker AstraZeneca PLC . The drug is for women whose ovarian cancer is associated with certain defective genes and whose cancer persists after multiple treatments.
Tags: test
approved
drug
cancer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||